Browsing Tag
Merz Therapeutics
2 posts
Merz triples debut Schuldschein to €450m as its healthcare funding base expands
The family-owned healthcare group has converted strong lender demand into €450 million of long-term capital, but returns will depend on how selectively it deploys the additional debt.
Merz Therapeutics acquires INBRIJA and FAMPYRA from Acorda Therapeutics to bolster neurological portfolio
In a strategic move enhancing its presence in the neurology sector, Merz Therapeutics has successfully completed the acquisition…